Do¢usEqn Envelope ID.. BF493428-4E8F4E(c-gB03-BC907044CFFS
Registered number: 08236220
Charlty numbers: q 15143 & SC045615
DEMENTIA RESEARCH UK
{A Company Limited by Guarantoo)
CONSOLIDATED TRUSTEES. REPORT AND AUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

Docuslgn Envelope ID.. 8F493426-4E8F4EOC-9B03-&C907044CFF5
DEMENTIA RESEARCH UK
(A Company Llmlted by Guarantee)
CONTENTS
Page
Reference and admlnlstratlve detalls of the Company. Its Trustees and advlser$
Tru$tees' report
Independent auditorfs report on the financial statements
Consolidated statemènt of Ilnanclal actlvitles
8-10
Consolldated balance sheet
12-13
Company balance sheet
Con501idated statement of cash flows
14-15
16
Notes to the tlnancial statements
17-28

Docusign Envebpe ID.. 8F4934284E8F4EOC-9803-BC907044CFFS
DEMENTIA RESEARCH UK
(A Company Llmlted by Guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY. rrs TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31 OCTOBER 2023
Trustees
W Liiybourn
T Thompson
L Bechelel
J Runicles
Company reglstered
numb¥r
08236220
Charity reglst&red
numbers
115143 and SC045615
Reylstered offlce
207 Regent Slreel
Lonclon
W1B3HH
Company sècrétary
W LaybDurn
Indèpendènt auditor
Cotsper Parry Group Llmlted
statutory Akjdilor
178 Btjckingham Avenue
Slough
Berkshire
SL14RD
Bankers
Unity Trust Bank
4 Brindley Place
BiTmingham
B12JB
Soll¢itors
Batos Wells
10 Queen Street Place
London
EC4R IBE
Page 1

Docusign Enveknpe ID.. 8F4934284E8F4eoc-9B03-BC9D7044CFF5
DEMENTIA RESEARCH UK
{A Company Llmlted by Guarantefr)
TRUSTEES. REPORT
FOR THE YEAR ENDED 31 OCTOBER 2023
The Trustees (who are also dire¢lors for Ihe purp(>ses of the Companies Ad 20081 present their report wllh the
financial statsmenls of the Group for the year ended 31 October 2023. The Trustees have adopted the
provisiDns of Accounting and Reporting by Charities.. Statement of Recommended PracliGe applicable to
charities preparing their accounts in accordance with the Financial Raportino Standard applicable in tha UK and
Republic ol Ireland IFRS 1021 leffe¢live 1 January 20151.
Structure. governance and management
Constitution
The Company is registered as a charitable company limited by guarantee and was sel up by a Memomndum of
Association on 2 October 2012.
The Company is constituted under a Memorandum of Association dated 2 October 2012 and is registered with
the Charity Commission number 1154143 and Scottish Charity Regulator SC045615.
b. 14Jethods of Èppolntment or ele¢tlon of Tru8teo$
The management of th& Company is the responsibillly of the Trustees who are elected and co-opted und9r the
terms of the Articles of Association.
The Trustees who served during the perlod were as follows:
W Laybourn
T Thompson
L B8ch81et Iresign8d 31 D8c6mbar 20231
J Runicles lappoinled 19 July 20231
M Evans (resigned 31 DeceTnber 20221
Objectives and acllvitlas
a. Poll¢les and oble¢tlvos
The Memorandum and Articles of AssDGiation defines the obj8cttves of thB Group..
To protect and promote the health of the public in particular by research into the nature. causes, diagnosis,
prevention, treatment and care of all forrns of dementia. including the development of findings of research into
the praclical appli¢alions for the prevention and Irealmenl of d¢m¥ntia and care of those suffering from
dèmentia and in furthÈr8ncÈ of that p￿Mary object, lo provide informatlon and ralse public awareness and
understanding of such matters.
b. Activlties undertaken lo achl•va obJa¢tlv98
The Group carries DUI these objectives by funding research related to the treatment and cure of dementia and
related diseases. The research funded is both pure and applied. Pure research has the ultimate aim of
eradicating Ihe dlsease whlle applled research Is aimed al Smprovlng the Ilves of those Ilvlng wlth dewnentla and
their caTer8.
c. Public bonefit
The Trustees confirm that they have referred to the guidance contained in the Charity Commission's general
guidance on public benefit when reviewing the Group's aims and objectives and in planning future activities.
Page 2

Ducusign Enveknpe ID.. gF493428-4E8F4EOC-9B03-BC907044CFFS
DEMENTIA RESEARCH UK
IA Company Limited by Guarantee)
TRUSTEES. REPORT {CONTINUEDI
FOR THE YEAR ENDED 31 OCTOBER 2023
Achlevements and performance
a. Golng ¢oncern
After making approprlale enqulries, the Trustees hav6 a re8SDnabl& expeclalSon that the Company has
adequate resour￿$ to continue in operation21 existence for the foreseeable future. For this reason, thgy
CDntinug to adopt th8 going concem basis in preparing the financial stalemenls. Further details regarding th8
adoption of th8 golng concBrn basls can be found In the ac¢ounling policies below.
b. Revlew of activltTes
In the financial year ending 31st October 2023, incomSng resources lolalled £1,048,256 12022 - £597,701)
resLJlling from voluntary donations, legacies, and gift aid. Fundraising expenses lotalled £213.709 12022
£144,575) providing a surplus of £834,547 before governance costs of £21,647. A total of £653.944 was
allocated to charitable activities Igranls £385,000) giving rSse lo a surplus for the year of £158,956. Adding this
surplus to unreslrided funds brought forward of £305,207 provides the balance of unreslriclad funds ¢8riied
fO￿ard lotalling £464,183.
The Group's grant￿[VIng programm8
The Group raises funds for rese8rch projects across the dementia community in all Tegions ol the UK. The
Group's funding covers every type of dgmonlia, ralher than any individual disease. Consequently. the income
ralsed by the Group can be allocated across a wd8 r8ng8 of r8s8arch proj8Cts in the damentia community
where the Group's intention is to tnake a positive impact on as many people as possible who are living with any
fomi of dementia, together with Ihelr families and carers,
In funding resear¢h, tha Group racognisès the n8@d to undertakB pur8 research with the aim of alleviating and
8V8nlually eradicating the disease, but it also recognlstss tho needs of those living with dementia and the
research needed lo improve the quality of thelr Ilves. Applied research, undertak8n lo halp those Dn thèlr
damantia journey. is c8nlred on car6 8nd compassion. This type of research examines patterns of care in order
lo meet appropriat8 and ever-changing ne8ds together with the use of relevant. up-lo-dale asBislive technology.
Recent stalislics now place dementia among the leadino causes of death in the UK and th8 provision of 8nd.of-
life care is 8 high priority for all concerned. The exienl. availability and c4)81 eff8CtiV8ne8s of such caro Is an
unavoidable fiel(1 for dementia research in the UK.
The Group's granl-giving programme currently supports largè-scale dementl8 mséareh pmjects within
universities and hospitals. looking into new ways of diagnosing and tr8aling dementia and into the availability of
end-of-life care for people with dementia. Thp Group also provides funds lo regional cenlres across th& UK
which dèlivèr SeNices and support directly to peopl8 wilh dementia. while carrying out research with those wtrvj
use their services lo further identify ngw foms of support.
The Group is very specific in its identification of potential grant rècipients. Currently, applications for grants arè
not actively sought. The Group carries out detailed research lo identify organisations operating in tho relevant
flelds of pure and applled research, which adhere most olosely to the Group's objectives.
The primary beneficiaries for the Group are those organisations which receive grants from the Group.
Secondary beneficiaries are those who benefit from the research and servic95 provlded by the grant recipients,
l.e., people wllh dementia, their famili?s and carers and the health professionals who support them.
Purè rè5ear¢h
The Dementia Research Centre at The Nallonal Hospital for Neurology and Neurosurgery has been Ihe
principal recipient of the Group's grants for pure research. The work of the Research Cenlre, Situated within
University College London, focuses on identilying the disease processes that cause dementia with a vlew to
understanding the factors that influence thotse pro¢esses in Order lo find ways lo improve diagnosis and
traalmenl. A grant of £100.000 has ba&n awarded for this year (2Q22- £100,000>.
Pag8 3

DO￿SIgn Envelopp ID.. 8F4934284E8F4EOC-gB03-BC907044CFF5
DEMENTIA RESEARCH UK
IA Company Limlted by Guaranteol
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
A¢hlevements and perfomiance (continued}
Applied research
Applled research grants are made In reGognilion of the fact that Slgrsificant improvements In quallty of life can be
achieved when peoplg wlth d8menlia are segn as having a number of partially remediable disabilities, rather
than an ill-defined mix of irreversible cerebral incompeionde5 that Is so often assumed. A number of Dementia
Services Development Centres IDSDCS) have been established which promotè this concept across the UK.
The DSDC was originally developed at Slirling University and the Group has continued lo award grants lo this
university to support DSDCS in Scotland and Northern Ireland IBelfast}. Grants for this year lo18lled £35,000
12022 - £20,000). A smaller grant of £2,500 was awarded lo SliHing's Dementia Services Development Trust
(2Q22- £2,500).
The DSDC in England, Tront D¢menlia, has been awarded 8n annual grant of £50.000 in 202312022- £40,000)
and the DSDC in Wales al Bangor University has been awarded £22,50012022 - £10.0001-
The DSDCS are active in the provision of services, advi￿, social and practical support and events. They also
undertake r8sgarch, conlred on the needs of people with dementia, the re8ulls of which are u%Éd lo devekjp
new and innovglive services. Through Ihair r8s8arch and ongoing conversations with people with dementia.
their families and carers. the DSDGS are wBII-posllloncd lo uncover areos of unmet need. The Group's role lft
supporting the DSDC network enables the Group to help improve the day lo day Ilves of people wilh demenlia
and lo identify the services and sUPPOrt they may need in the future.
The Research Inslilule for the Care of Oldor Poople IRICEI is an inlernalionally renowned dementia research
and treatment centre located al the Royal Unlled Hospital in Bath. RICE is an indep9ndenl organisation which
delivers essonlial resear¢h into dementia and provides support for pwple living with dÉmanli8. Although RICE'S
resaarch focus is prirnarily on dam&nlia, the Insb'lule also investigates other chronic conditions Df older ag6 in
order lo understand their connections to dementia and the increasingly complex needs of a growing. agelng
population. A grant of £25,000 was awarded to RICE in 2023 {2022- £10,QOOI.
End.of-life c4re
Dementia is arnong the leading causes of death in the UK bul th8 8xl8nl and availability of end-of-life care for
d8m6ntia patients is variable and inconsislenl. The imprecise boundaries of health and social care can be
Pgrplexing lo patients, carers and their families whan seeking help at crltlcal times. The funding of 6nd-of-lrfe
dre can also vary between reglons and health ¢are providers. adding to an already confused plclure. The
Cicely Saunders Institute based at Klngs Colloge London is 8 centrè for rèsaarch into the provision of end-of-life
cara in the UK. A grant of £100,000 has been awarded lo the Institute {2022 - £100,000) lo assess the cost and
availabilily of end-of-lifg care for damentia patients, together wllh the potential for improving access to such care
throughout the UK.
Naw grant rocipi8nt5
The Group raviewed ils grant-making progrdmme in late 2022, with a view to Identi￿ng polenllal new grant
reclplenls. The objecllves were lo pinpoint new organisatlons which fil the GTOUP'8 crlterla of conduding pur8 or
applied research, bul which also provided opportunities for the Group to extend ils granl-making impact into
new areas of dementia Tesearch or Into new regions of the UK. Four new organisalions were identified which
matched th6 Group's grant-making objectiv85 and which subsequently 8￿pIed the Group's offer ol funding, as
desGrlbed below.
The research carrled out by the Againg and Dementia Research Cenlre {ADRCI al Bournemouth University falls
into three broad categories.. dgv61oping ageing and dementia-friendly environments, nutrition and wellbe1ng, and
a¢livity and social inclusion. The rese8r¢h carried out al the ADRC significantly impacts on theory, education
and professional practice relating to demsnlia. and the research team has developed a number of resources to
guide families, carers, and healthcare professionals on how best lo help people wlh éemonlia. A grant of
£20,000 was awarded lo the Centre in 2023.
Page 4

D(KusEgn Envebpb10.' 8F49342B-4EeF4E(￿-9Bo3-￿c907o44CFF5
DEMENTIA RESEARCH UK
IA Company Limited by Guarantee)
TRLISTEES. REPORT (CONTINUED}
FOR THE YEAR ENDED 31 OCTOBER 2023
Achievements and performance {continuedl
Dementia Prevention UK is a registered charity which provides educatlon to men, women and children from
undsrserved wrnrnunilie5 on demonlia Tisk factors and practical tools lo prevent or delay dementia through
lifestyle modificallon. Their innovative ￿searCh and workshop programme5 focus on how behaviours can
impact the brain, and on the measures which Individuals can lake to malnlain braln health and protect the brain.
A grant of £10,000 was awarded lo Dementi4 Pr8venllon UK In 2023.
Music for my Mind Is a registered charity which promotes the use of personalised music as an effective Iherapy
for people who are living with dementia. Their research inv6slig8t8s how music can impmva tha wÈllbeing of
people with dementia and help to relieve anxiety and depression. The charity has developed ¢)ew technology
which enables personalised playlis18 to be c￿￿ted quickly and easily, based on an individual's background and
musical preferÈn¢es. for use wilhln a care home or an individLEal's own home. A grant of £10,QOO was awarded
to Music for my Mind in 2023.
M8mory M81ters Is a Communlty Interest Company that has been managlng prolecls and servlces for peopl8
with dementia for over 12 years. A Memory Matters Hub provides advice and praclical support for anyone
concerned about memory loss or dementia. Memory Matters offers Cognitive Stimulation Therapy ICSTI to help
those living with dementia to improve Iheir ¢ognitive abilities and quality of life and has dev8loped the first CST
e-group thgrapy app, which can be used d1￿cl1Y by someone who has dementia. A grant of £10,000 was
awardod to Memc>ry Mattèrs In 2023.
Group websltè
The Group launched Its now w6bsito in January 2023. The key objectives of the new website are lo showcase
more detalled Information about the impael of th8 Group and thè scope of ils granl-giving programme, whilst
also providing users with access lo expert resources about dementia in order lo support the Group's staled
objective 'to provid6 informatlon and fdiS8 public aw8rèn8ss and understanding of dementia,. Detailed
informallon Is provlded about all of tha Group's grant reclpienls and the work undertaken. The Group now also
benefits from enhanced user analytlcs whlch have been establtshed for the new webslle, helping lo direct future
conlenl and funclionglity.
Throughout the ¢Durso of 2023, enhancements were made to Ihg new website, including the introduction of a
Blog to present conlenl from expert conlribulc>rs, tha creation of a new 'Donale' page designed to make il as
easy as possible for donors to donate through a variety of online and offline channels and the introduction of
measures to improve the website's search engine oplimisalion or SEO. The website will ¢onlinue lo be
eveloped throughout the course of 2024 to help dellver new Income streams for the Group, Induding the
launch of ils onllno storo.
Trading company
In November 202Z, the Charty 6St8blished a tradlng company, Dementia Rosearch Tradlng Limited. lo manage
ils futur8 trading operations.
Page 5

Ducuslgn Env@IopB ID.. 8F49342B4E8F4EOC-9B03-BC907044CFF5
DEMENTIA RESEARCH UK
(A Company Llmlted by Guarantse}
TRUSTEES, REPORT (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
Financial review and future plans
The Trus1605 arg salisfi¥d with Ihe financlal position at the year ended 31st October 2023 and the
17nanaal performan￿ described above.
a. Rasory&$ pollcy
The Trustees review rèservès regularly in order lo ensurè that the Grtsup is in a position to meet all ils current
and anlicipaled future commitments. Reserves are defined as that part of a Group's unreslricled funds that is
f￿elY available lo spend on any of the Group'8 purposes. As a matter of policy, reserves are held in order lo
cover six months of anticipated expenditure whenever possible.
As of 31st October 2023. reserv&s 01 £464,000 were held represenllng approxlmaloly slx months of anlicipaled
expenditure in the year ahead. In comparison. at 31st October 2022 reserves of £305,000 were held
ropresenting five months of actual oxpendiluro tolalling £800,000 in the year under review.
The Group does not awaid grants for a period greater than twelve months and it only awards grants which are
covered by available reserves. The minimum lev81 of reserves that the Group requires lo meet its commitments
and conllnu8 lrndlng Sn any ￿e1ve month period is eslimateé at £250.000.
b. Plans for the future
The Success which the Group has seen in 2023 In tfjrms of ils fundraising returns will form the basFS of ils
activity in 2024. The webslte will be further developed lo maximlse Income and us8r engagament and the
careful use of new data to largel priority prospects will continue. The Group will b¥Jild on its relationships with ils
grant recipients via naw contant collabDralions for th8 Website together with new joint promotional and other
fundraising activities.
Thg Group conllnu8s to onsure that Ihg prolecls it pursues are realistic. sustainable. and have maxlmum Impact
at minimum CDSI, whilst ansuring that fundraising activity and the income that fundraising generates, is not
disrupted. The Trustees do not anliThpale any signifiBanl changg lo the ¢osl of external resources required to
support the current aclivilles tsf th8 Group. All the projects are managed in-hous8, with axlsrnal résourcas only
being brought in where it is critical lo the success of the project. Any additional resource r8quired to 8UPPOrt the
Group's new fundraising strategy will be kept to a minimum and will be subject lo careful tendering and review
processes.
All the necessary insurances and legal obligations lo support the Group's current activities ar8 in placo and the
Group has Conducted a full risk analysis of its operation. Any addilional requirements for new projècts wlll be PLtI
Sn plac8 as thè r818vant projacls ara impl8m8nlèd.
Small company prov151ons
In preparing this report. the TTUStees have taken advantage of Ihe small companles exempllons provided by
section 415A of the Companles Act 2006.
structuraj govèrnance and managemant
Governlng document
The Group is controlled by ils governing document, a deed of trusL and conslilutes a limlted company, limited
by guarantee, as defined by the Companles Act 2006.
Pag8 6

Docusign Envelope ID.. 8F493428.4E8F4EOC.9803-8W7044CFF5
DEMENTIA RESEARCH UK
{A Company Llmlted by Guarantee)
TRUSTEES, REPORT ICONTINUEDI
FOR THE YEAR ENDED 31 OCTOBER 2023
Events slnce tho end of the year
Information relalillg lo events since the 8nd of the year is given in the nolB8 to the financial slalements.
statement of Trustees. responslblllties
The Truste?s (who are also the directors of the Company for the purprjses of company lawl are responsible for
preparing the Trusteés, report and IhÈ financial slalèmÈnls in accordanc6 with 8pplicable law and United
Kingdom Accounting Standards (United Kingdom Generally Accepted Accauntlng Practice}.
Company law requires the Trustees to prepare financial slatementg for each financial year. Under company law,
the Trustees must not approve the financlal statements unless they are satisfied that they give a true and fair
vlew of the slate of affairs of the Group and the Company and of their incoming resources and application of
resources. Including their income and expènditure, for that perlod. In p￿parIng these financ(al ststements, the
Trustees are required lo..
select suitable accounting policies and then apply them consi$tenlly-
observe the methods and principles of the Charities SORP IFRS 102).,
make judgements and accounting estimates that are reasonable and prudent.,
stale whether applicable UK Accounting Standards {FRS 1021 have been followed, sublècl to any
material departures disclosed ancl explained in the financial slalements.,
prepare the financial statements Dn the going concern basis unless il is Inappropriate lo presume that the
Group will continue in business.
The Trust86s are responsible for keeping adequ818 accounting records th81 arg sufficient lo show and explain
the Group and the Companys transa¢lh)ns and disclose with reasonable a¢¢ura¢y al any lim8 th8 finan¢i81
position of the Group and the Company and enable them to ensure that the financial ststements comply with the
Companies Act 20D6. They are also Tesponsible for safeguarding the assets of the Group and the Company
and h8nc8 br taking rèAsonabl8 staps for thé prèvèntion and dalection of fraud Bnd other Irregul8rilles.
In so far as Ihg Trustees are aware:
there is no relevant audit information of which the Group's auditor is unawarg, and
the Trustees havg taken all the steps that ought to have been taken as Trustees In order lo be aware of any
relevant audit information and to establlsh that the Gioup's audllor Is awar8 of that Inform811on.
Audltor
The audit business of Halnes Watts was acqulred by Cooper Parry Group Limlted on 14 Nov8mber 2023.
Haings
Watts has resigned as auditor 2nd Cooper Parry Group Limited has been appointed in ils place.
Tha auditor, CoDpor Parry Group Llmited, has indtcated his willingness to continue in office. The designated
Trustees wlll propose a mollon reappolnling the auditor at a meeting of the Trustees.
Approv8d by ord8r of the metnbers of the board ofTrusleg3 and signed on their behalf by..
Duw¥lgllodty'.
sb
4I6F562
oe5MBB..
TThomp50ll
Secretary
Date., 29 Jul y 2024
Page 7

D￿s1On Envebpe ID.. 8F4934284EeF4EOC-9B03-BCg)7044CFF5
DEMENTIA RESEARCH UK
IA Company Llmltfrd by Guarantee)
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF DEMENTIA RESEARCH UK
Opinion
W8 havè audiled the financial Statemen￿ of Dementia Research UK (the 'parenl charitable companJll 8nd ils
subsidiaries Ilhe 'GrDiSP'I for the year ended 31 Oclober 2023 which comprise the ConsDlidaled statement of
financial activities, the Consolidated balance sheet, the Company balance sheet, the Consolidated slalement of
cash flows and the related notes, irbduding a summary of significant accounting poliGle8. The financial reporting
framework that has been applied in their preparatlon is applicable law and Unlted Klngdom Accountlng
Standards, includlng Flnancial Reporting Standard 102 'The Financial Reporiing Standard applicable In the UK
and Republlc of Ireland, Iunlted Klngdom Generally A¢cepted A¢¢ounling Praclicel.
In our opinlon the financial slalements:
give a true and fair view of the state of the Group's and of the parent charilablu companws affairs as at 31
October 2023 and of the Group's Incoming resouT¢es and application of resources, including ils income
and expendlture for the year then erided..
have been properly prepared in accordance wth United Klngdom Generally Accepted Accounting
Practice,. and
have been prepared in accordance with the requirements of the Charities Act 2011, the Charities and
Trusteg Investment (Scottandl Act 2005 and regulations 6 and 8 of the Charilles Accounts Iscolland)
Regulaliorks 20D6.
Basls for oplnion
We conducted our audit In accordance wSlh Inlematlonal Standards on Audlling {UKI IISAS IUKII and applicable
law. Our responsibilities under those standards are furtheT described in th& Auditor's responsibilities for th& audit
of the financial statements section of ou¥ report. We are independent of th8 Group in accordance with the
glhlcal requirements that are relevant lo our audit of the financial slalements in the United Klngdom, including
the Financial Reporting Council's Ethical Standard, and wa hAV8 fulfillad our other ethical responsibilities in
accordance with these requirements. We believe that the audit gvldgnce we havo oblalnod Is sufficient and
appropriate to provide a basis for our Dplnlon.
Conclusions rÈlating to going concern
In audltlng th8 financ181 stalemenls, w8 have concluded that the Trustees, use of the going concern basis of
accounting in the preparation of the financial statoments18 appropriate.
Based on the work we have performed, we have not identified any material un¢ertainlles rel81ing lo evants or
conditions that, individually or coll&clively, may cast significant doubt on the Group's or the parent chaTitable
companvs abillty lo continue as a going concern for a p$riod of al least tsv8lv8 months from when th8 financial
sta18ments are aulhorised for issue.
Our responslbililies ané the responsibilities of the TTUSt8es wth rpspecl to golng concgrn arb des¢rfbed in the
relevant seolions of this report.
Page 8

Ducusign Envplopp ID.. 8F493428-4E8F4EOC-9B03-BC907044CFF5
DEMENTIA RESEARCH UK
(A Company Limited by Guarantee}
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF DEMENTIA RESEARCH UK ICONTINUEDI
other Infomiatlon
The other information comprise$ the information included In the Annual r8POrt other than thè financial
statements and our Auditor's report Ihereon. The Ttuslees are responsible foi the other information contained
within the Annual report. Our opinion on the financial slalements does not cover the other information and,
except to the exlenl olhenNise explicitly staled in our report, we do not express any form of assurance or
¢onclusSon Ihereon. Our responslbillly 1$ lo read the other information and, in doing so, consider whether the
other Inlormallon Is materlally Inconsistent with the financlal sl8lements or our knowledge obtalned In tho cours
of the audit, or otherwise appears to be materially misstated. If we identify such malerlal Inconslslencies or
apparent material misstatements, we are required lo determine whether this gives rise lo a material
misslatemonl in the financial slalemenls Ihemselves. If, based on the work we have perfDrmed, we conclude
that there is a material misstatement of this other information, we are required lo report that fact.
We have nothing to report in this regard.
atters on whlch we arè rÈquired to report by exception
We have nolhlng io report In respect of Ihe followlro mallers where th8 Charltios (Accounts and Roportsl
Regulations 2008 and the CharStles Accounts {Scotlandl Ragulalions 2006 las amended} requires us to report
to you if, in our opinion=
the information given in the Trustees, report is Inconslstent in any matedal respect wlth the flnancial
statements,. or
the parent charitable company has not kept 8uffici8nl and proper accounllng records.. or
the pargnt challlable company financlal statements arè not in agreement wlth the accounting records and
returns.. or
we have not received all the information and explanations we raquire for our audiL
Responsibllities of Trustees
As gxplained moro fully in thè Truste&s' responsibilities slalem8nl, the Trustees {who are also the directors of
the charitable company for the purposes of company lawl are responsible for the prepar8lion of the financial
slalements and for being satisfied that they give a true and fair view. and for such internal control as the
Truste&s d8tarmin8 is nacessary to 8n8bl8 th8 prèparalion of financial statements that are frBe from material
misslatemenl, whèther due to fraud or error.
In preparing the financlal sta19ments, tho Truslggs arè responslblo for ass&s$lng the Group's and the parent
oharilable companls ability to continue as a going concern. disclosing, as applicable, matters related to going
concern and using the going concern basis of ac¢ounling unless the Trustees either intend to liquidate the
Group or the parent charitable company or lo cease opérations, or have no raalislic altemative but lo do so.
Auditor's responslbllltles for the audlt of the flnanclal statements
We have b8en appointed as auditor under section 151 of the Charilles Act 2011 and secllon 4411)Ic) of the
Charities and Trustee Investment (ScDllandl Act 2005 and report In accordance with the Act and relèvant
regulalionb mad8 or having elfecl Ihereunder.
Our objectyves are to Dbtain ￿&SOnable assurance about whether the financial statements as a whole ar2 free
from matèri81 misslalèmenl, whether duo lo fraud or error, and to issue an Auditor's report that includes our
opinion. Reasonable assurance Is a hSgh level of 8ssuran¢e. bul is not a guar8nte8 that 8n audit conducted i
accordance with ISAS IUKI will always deleGI a material misslalemenl when it exists. Misstslomenls can arise
from fraud or error and are considered material if. individually or in the aggregate. they could reasonably be
expected to influence thè econornic decisions of users taken on the basis of these financial slatemenls.
Pag8 9

Docusign Envelope ID.. 8F49342PAE8F4EOC-gB03-BC907044CFFS
DEMENTIA RESEARCH UK
IA Company Limited by Guarantee)
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF DEMENTIA RESEARCH UK ICONTINUEDI
Irregularities. indtsdlng fraud, are Inslancos of non-compllance wllh laws and regulations. We de8ign
prO￿d￿re$ in Ilne with our responsibilities, outlined above, to detect materlal mlsstatements in respect of
irregul8rit19s, induding fraud. The extent to which our procedures are Gapabl8 of deleGling irregularilies.
including fraud is detailed below..
We gained an understanding ot the legal and regulatory fFamework applicable lo the ￿rnPany and Ihe Industry
in which il operates, and considered the risk of acts by the company that were contrary to applicable laws and
regulations, Including fiaud, Wo discussed with the directors the policies and procedures In place regardi
compllance w]Ih laws and regulations. We discussed amongst the audit team the identified laws arK£
regulations. and remained alert lo any indications of non-¢omplianco.
During the audit we focussed on laws and regulations which could reasonably bo expected lo give ri88 to a
material misstatement in the financial slalamants, including, bul not limited to, the Companies Act 2006 and
Charities Act 2011.
Our procèdures in r8laliDn to fr8ud. Induded bul were not limileLt to= enquiring of management whether they
have any knowledge of any actual, suspected or alleged fraud, and discusslons amongst th8 audll team
regarding risk of fraud such as opportunities for ffaudulonl manipulation of financial statements.. review of
meeting minutes.. and using analylical procedures lo Identify any unusual or unèxp8Ct8d relationships. We also
addressed tre risk of m8nag8rnent override of internal controls. including lesling journals and evaluating
whether there was evldoncg of bias by the directors that represented a risk of material misst8lèmenl du8 10
fraud. Our lesls Included agreelng the flnanci81 statement disclosures to underfying supporting documenlallon.
Because of the Inherent limitations of an audit, there is a rlsk that we ￿11 not detect all irregularities, includlng
those leading to a material misslatemenl In the financlal statements or non-complianc8 with regulation. This risk
increases th8 mora that complianc8 with a law or regulation is removed from th8 ovenls and transactions
reflectgd in the financial slalomonls, as we will be less likely lo becoma awar8 01 instances of non-compliance.
The risk is also greater regarding irregularities occurring due lo fraud rather than erroT. as fraud involvgs
intentional concealment. forgery. collusion. omission or misrepresentation.
A further des¢ription of our responsibilities for the audit of thè financlal statements Is located on the Flnancial
Reportlng Council's website al.. wwN.frc.Dr
.ukJaudilorsres
onsibililies. This description forms part of our
Auditorfs reporL
Uso of our raport
This report is made solely lo the chaiilable companls Trustees. as 8 body, in accordance with Part 4 of the
Ch8rilies {Accounls and Reports) R&gulat40ns 2D08 and regulation 10 of the Charilles Accounts IScoll8ndl
Regulations 2006. Our audit work has been undertaken so that W6 might slate to the charitable companls
Trustees those matters we are required lo stale lo them in an AudllDr's report and for no other purpose. To the
fullest exlenl permitted by law, we do not accept or assume responsibility to anyone other than the charitable
company and ils members, as a body, for our audit work. for this report, or for the opinions wa havo formod.
Coopèr Parry Group Limited
Slalulory Auditor
178 Buckingham Avenue
Slough
Berkshlre
SL14RD
Date.. 2910712024
Cooper Pary Group Llmlled are ellgible lo act as auditors in term8 of 8ecllon 1212 of the Companies Ael 21M)6.
Page 10

Do￿￿gn Envebpe ID.. 8F4934284E8F4EOC-9B03.Bcg07044CFFS
DEMENTIA RESEARCH UK
IA Company Llmlled by Guarantee)
CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND
EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31 OCTOBER 2023
Total
funds
Charity only
2022
Unrestricted
funds
2023
Total
funds
2023
Note
IncoTne from:
Donations and legacies
1,t)48,256
1,048,256
597,701
Total Income
1,048,256
1.048,256
597,701
Expenditure on:
Raising funds
Charitable aBtivi11&s
213,709
675,591
213,709
675,591
144,575
385,324
Total expgndituro
889,300
889,300
529,899
Net movement In funds
158,956
158,956
67,802
Reconclllatlon of funds..
Total funds brought fonmard
Not movomenl in funds
305,207
158,956
305,207
158,956
237,405
67,802
Total funds carried forward
464,163
464,163
305.207
The Consolidated statement of financial aGlivilies includes all gains and losses recognised in the year.
The notes on pages 17 10 28 form part of these financial statements.
Page 11

Docusign Envelope ID.. 8F4934284E8F4EOC.9B03.BC907044CFFS
DEMENTIA RESEARCH UK
A Company Llmited by Guarantee)
REGISTERED NUMBER: 08236220
CONSOLIDATED BALANCE SHEET
ASAT 31 OCTOBER 2023
2022
Charlty only
2023
Noto
Fixed assets
Current a55ets
DebloTS
12
42,970
542,302
35,806
324,602
Cash at bank and in hand
585,272
360,408
Creditors.. amounts falling due within one
year
13
{121,10SI
155,201)
Net current assets
464,163
305.207
Totsl ass&ts less current Ilabllltles
464.163
305,207
Total net 8s8ets
464,163
305,207
Charlty funds
Reslricled lunds
Unreslriclgd funds
15
15
464,163
305,207
Total funds
464.163
305.207
Page 12

Do￿￿19n Erwelope ID.. 8F4934284E8F4EOc-9BO&BC￿j7o44CFF5
DEMENTIA RESEARCH UK
IA Company Llmited by Guar#nteel
CONSOLIDATED BALANCE SHEET ICONTINUEDI
AS AT 31 OCTOBER 2023
The Company was enlltled to exemption from audit under secllon 477 of th6 Companles Act 2006.
The members have not required the entity to obtain an audit foT the year in quesllon in accordance with section
476 of the Companies Ad 2006.
However, an audil is required in accordance with s@clion 151 of the ChaTilies Act 2011 and sedion 441111¢} of
the Charities and Trijstee Investment (Scotlandl Act 2005.
The Trustees acknowledge their responsibilits'ès for Complying with the r8quirém6nts of the Act with respect to
accounting record5 and preparation of finaFicial slatemenls.
The financial slalements have been prepared accordance wilh the provisions applicable to enlilies subject tu
the sma11 companies regimg.
The financial statements were approved and authorlsed for issue by thè Trustees and signed on their beh8W by..
oiu8L4n•d by..
448FgB2
D69e4B8...
T Thompson
29 July 2024
Date..
The notes on pages 17 to 28 form part of these financial stalemenls.
Page 13

Docu$i9n Envdq)e ID: 8F493428-4EBF4EOC4B03-BCP07044CFF5
DEMENTIA RESEARCH UK
IA Company Limited by Guarantefrl
REGISTERED NUMBER.. 08236220
COMPANY STATEMENT OF FINANCIAL POSITION
AS AT 31 OCTOBER 2023
2023
2022
Note
Flxed assets
Investments
11
100,002
100,002
Current assets
Debtors
Cash at bank and in hand
12
42,835
519,930
35,808
324.602
562.765
360,408
Creditors.. amounts falling due wilhln ono
year
13
1108,6501
155.2011
Ntst current assets
454,115
305.207
Total assgts less current Ilabilities
554,117
305,207
Total net assèts
554,117
305.207
Charlty funds
Reslricl8d funds
Unreslricled ftjnds
15
15
554,1 f7
305,207
Total funds
554,117
305.207
P2g6 14

Do¢uslgn Enyebpe ID.. 8F493428-4g8F4EOC-gB03-BC907044CFF5
DEMENTIA RESEARCH UK
IA Company Llmited by Guarantee)
COMPANY STATEMENT OF FINANCIAL POSITION {CONTINUED)
AS AT 31 OCTOBER 2023
The Companys nel movement in funds for the year was £248,910 {2022 - £67,802}.
The Company was trnlilled to examplion from audit under secllon 477 of the Companies A¢1 2DO6.
The members have not required the entity to oblain an audit for Ihe year in question in accordance with secllon
476 of Ihe Companies Act 2006.
However, an audll Is requlred In accordance wlth section 151 of the Charities Act 2011 and $o¢lion 4411llcl of
the Charities and Trustee Investmènt (Scolland) Act 2005
The Trustees acknowledge their responsibilities for complying wllh the requlrements of the Act with respect to
accounting records and prepar81ion of financial statements.
The financial statèments have been prepared in accordance with the provisions applicable lo entillos subject to
the small Gompani8s regime.
The financial statements were approved and aulhorised for issue by the fruslees and 8lgned on Ihelr behalf by..
po¢usiw*d by..
448F$02
089ts8e..
T Thompson
29 July 2024
Dalg..
The notes on pages 17 to 28 fomi part of these fin8r¥cial sl8tèm8nts.
Page 15

DuCU￿￿ Erweknpe ID.- 8F4934284E8F4EOC-9803-BC907044CFFS
DEMENTIA RESEARCH UK
IA Company Llmlted by Guarantee)
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 OCTOBER 2023
2023
2022
Cash flows from operating activities
Nel cash used in operating activities
217,700
86,809
Change In cash and cash equlvalent5 In the year
Cash and cash equivalents al the beginning of the year
217.700
86,809
324,602
237,793
Cash and cash equlvalents at tho ond of thè y88r
542.302
324,602
The notes on pages 17 to 28 fomi part oflhese flnancial statements
Page 16

Docusign Envelope ID.. 8F493428-4EaF4EOC-9803-BC907044CFFS
DEMENTIA RESEARCH UK
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
Genèral Infomiatlon
Dernenlia Research UK is a private Company, Ilmiled by guarantee. incorporated in England and Walps
1082362201. The principal address of the Group is 207 Regent Sleet, London, W1B 3HH.
Accountlng pollcles
2.1 Basls of preparation of financlal statements
The fin8n¢i81 st8tementS are prepared in Sterfing {£) which Is the functlonal currency of the Charity.
The firiancial slalements are for the year ended 31 October 2023 12022., year ended 31 October
20221.
Tha financial statements have baen prepared in accordanc8 with the Charities SORP IFRS 1021
Accounting and Reporting by Char(ties'. Ststement of Recommonded Pra¢li¢e applicable lo charities
preparing their accounts in accordance with the Financial Reporting Sland8rd applicablè in th@ UK
and Republic of Ireland IFRS 1021 leffeclive 1 January 20191, the Financial Reporting Standard
appll¢able In the UK and Republic of Ireland {FRS 1021 and the Companies Act 2006.
Demenlla Research UK meets the definlllon of a public benefil entity und8r FRS 102. Assets and
li8bilili@s are initially recognised at historical cost or transaction value unless olh8rwiso slal&d in tho
r6levanl accounting policy.
Oll 1 Novembèr 2022 the chalily established a Ir8ding company, Dèm8nli8 Research Trading
Limited, lo manage ils future trading operations. Th8 Consolldaled slalement of financial activities
ISOFAI, Consolidated balance sheet and the nolgs to the financial statements for th6 ¢urrènl year
consolidata the finan￿al statements of the Company and its subsidiary undertaking. The results of
the subsldlary aro consolSdatcd on a line by line basis.
Th8 comparative figures shown in Ihg Gonsolidated Statement of financlal a¢tivilio¥ ISOFAI,
Consolid818d balance sheet and the Mles lo the financial slalenenls represent the position and
performanco of the Company only, as the only Group member in the pr(or year.
The Company has taken advantage of the exemption allowèd under sectlon 408 of the Companios
A¢1 2006 and has not presented its own Statement ol financial activities in these financial
statemen15. The pa￿nI charfly made a profit of £248,910.
2.2 Golng concern
The financial 5talom8nls havo been prepared on a going concern basis. which assumes that the
Company will continue in oper81ion81 exislènc8 for the for8s8aabl@ futLJre which the Trustees believe
to be appropriate.
Tho Charity Gonlinues to be able to reassurg ils donoTS, bgneflclarfes and stakeholders that the
a¢livily al th6 core of its fLJndraising is stable and sustainable. and that it is well placed to meet ils
objectives and lo support its beneficiaries.
2.3 Gompany status
The Company Is a company Ilmiled by guarantee. The members of the Cornpany are the Trustees
named on page 1. In the event of the Company being wouncl up, the liability in respect of the
guarantee is Ilmited lo £1 per member of the Company.
Page 17

DoGusign Envdope ID.- 8F493428-4E8F4EOC-gB03-BCW7044CFF5
DEMENTIA RESEARCH UK
IA Company Llmlted by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
A¢countlng pollcle$ {contlnued)
2.4 Income
All income is recognised once the Cotllpany has enltuemenl lo the income, it is probable Ihal the
income will be received and the amDunl of income re(Eivable can be measured reliably.
The recognition of Income from legac1es is dependent Dn estsblishlng enlillement. the probability of
receipt and the ability lo esllmate wllh sufflclenl accuracy the amounl receivable, Evidence of
8nlillement to 8 legacy exists when the Company has sufficient evidence that a glft has been left lo
them Ilhrough knowledge of the existence of a valid will and the death of the benelaclor) and the
executor is satisfied th21 the property in qtjestlon will not be rBquired lo satisfy claims in the estate.
Receipt of a legacy musl be recognlsed whon il is probable Ihal il will b8 received and the fair value
of the amount receivable. which will generally be the expected cash amount lo distributed lo the
Company, can be reliably n*asured.
Other income is recognised in the period In whlch it Is re¢elvable and to the extent the goods have
been pmvidBd or on complellDn of the 8èrvlce.
2.5 Expendlturo
Expenditure is recognised once there is a leg81 or conslru¢llvè obllgation lo transfer economi
benefit to 8 third party, it is probable that a transfer of economic benefit will be required in selllement
and thè amount of th6 obligation can be measured reliably. Expendlture Is class1fied by activlty. Th
costs of each activity are made up of the total of dired costs and shared costs, including support
costs involved In undgrtaking each activity. Direct costs allribulablè to 8 singl8 activity are allocated
directly lo that activity. Shared costs which contribute lo more than one activity and support cos
which are not altributsble lo a single Bctivity are apportioned between those activities on a basis
consistent with the use of r8sources. Cgntral staff costs are allocated on the basis of lime sp9nl, and
depreciation charggs allocatèd on the portion of the 8ssel's use.
Expendilurg on raising fvnds include5 all expenditure Incijrred by the Group lo ralse funds for tts
charitabl6 purposes and Includes costs of all fundraising 2clivilies. events and non-charftable
trading.
Expenditure on ¢harilable aclivilies is incurred on directly undertaklng the aclivili8s which furthèr the
Group's objectives, 8s w811 as any associated support costs.
Grants payable are charged in th8 year wh8n the offor is made except in those cases where the
offer is conditional, such grants being recognised as expendiluro when the conditions attaching are
fulfilled. Grants off8rad subject lo conditions which have not been mel at the year 8nd ar@ noted as a
committnenl, bul not accrued as exp&ndilura.
All expenditure 15 inclusive of irrecovgrable VAT.
2.6 Taxatlon
The Company is consldered to p8SS the tests set out in Paragraph I Schedule 6 of the Flnanc8 Act
2010 and therefore it meets the definition of a charllable company for UK corporation lax PUTposes.
Ac¢or(Jingly. the Company is potentially exempl from taxation in resp8¢1 of in¢ome or capital gains
raceiv8d within cal6go¥ies covered by Chapter 3 Part 11 of the CorpoTrlion Tax Act 2010 or Section
256 of th? Taxation of Chargeable Gains Act 1992, to the exlenl that such income or gains are
applied excluslvely to charitsble puiposes.
Page 18

t>ocuslgn Envelope ID: 8F49342B-4E8F4EOG-9B03-SG90Y044¢FF5
DEMENTIA RESEARCH UK
(Acompany Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
Accountlng pollcles (continued)
2.7 Investmènts
Fixed asset investments are an amount equal lo the capital contribullon provided trj the Iracling
subsidiary lo conliibute towards ils working capital and trading aclivilies.
Investments in subsidiaries are valued at cost less provlslon for ImpaSrment.
2.8 Debtorts
Trade and other debtors are recognised al the settlement amount 8fter any trade discount offered.
Prepayments are valued al the amount prepaid net of any trade dlscoL¢nls due.
2.9 Cash at bank and In hand
Cash at bank ènd in hand Includes cash and 8hort-lerm hlghly Ilquld investments with a short
malurlty of thro9 months or less from the dale of acquisllion or openlng of the deposit or similar
ac(x)unl.
2.10 Llabllltles and provlslons
Llabllltles Sre recognised when there Is 8n obligation al the Balance sheet date as a result of a past
event, it is probable that a transfer of Èconomlc banefil will be required In settlement, and the
8rnounl of the settlement can be eslimaled reliably.
Llabililies are récagnis8d at tha amount that the Company anticjpates it will pay to settle the debt or
the amount il has received as advanced payments for the goods or services it musl provide.
Provlslons are measured al the best eslimale of the amoL¢nts required to s&lU8 thè obl￿9110n. Where
the affect of Iha lim8 valua of money is material, th& provision is bas8d on the prtrsenl value of those
amounts, discounlod al the pre-tax discount ral& that Teflecls the risks specific lo the liability. The
unwinding of the dlscounl Is recognSsed In the Consolldaled slalement of financial aclivilles as 8
finance cost.
2.11 Flnancial in5trurnents
Financial assets and liabilities are recognised In the bal8n¢B sheet when the Company becomes a
party to thè contractual provisions of the inslrumenl.
Trade and other debtors and Creditors ara classified as basic financial instruments and measured al
Initial r8cognition al transaction price. Debtors and creditors are subsequently rneasured at
amortised cost using the effoclive irileresl rale method. A provislon Is eslablishod when there is
objectfve evldence that the Compariy wll not be able to collgct all amounts due.
Cash and cash oquivalents are Classified as basic financial instruments and comprisé cash in hand
and at bank whlch are integral parts of the Companls cash management.
Flnan¢lal liabilities and equity Instruments Issued by the Company are classlfled In accordance with
the subslanc@ of the coiilraclual arrangernents entered Into and the definitions of a financial liability
and an equity inslruménl.
An equity instrument is any contract that evidences a residual interest in the assets of the Company
aftor deduding all of its liabi1I1ies. Equlty Inslrum8nts issued by the Company are recorded al the
proceeds received, nel of direct issue costs.
Page 19

Docusyn Envelope ID,. 8F4934284E8F4EOC-9B03-BC907044CFFS
DEMENTIA RESEARCH UK
{A Company Llmited by Guarantoel
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
Accountlng pollcles (contlnued)
2.12 Pensions
The Group operates a d&fined contribution pgnsion scheme and th8 pension charge repres8nts the
amounts payable by the Group lo the fund in respect of the year.
2.13 Fund aecountlng
General funds are unrgstricled funds which are available for use al the discretion of the Trustees in
furiherance of the general objectives of the Gr(xJp and which have not bgen designated for olhgr
purposes.
Reslricled funds are funds whlch are to be used in accordence with specific restrictions imposed by
donors or which have been raised by the Group for particular purposes. The costs of raising and
adminSsterSng such funds are charged against the $peclfi¢ fund. The aim and use of each reslrlctsd
fund is set out in the notes lo the flnar)clal statements.
In¢omg from donatlons and legocles
Total
Total
funds
funds Charlty only
2023
2022
Unrestrlcted
funds
2023
Donations
357,070
691,186
357,070
691.186
291,905
305.796
Lagacias
1,048,256
1,Q48,256
597,701
All income from donations and legacies in the prior year was unrestricted.
Expendituro on ralslng funds
Costs of ralslng voluntary Incoma
Total
Total
funds
funds Charlty only
2023
2022
Unrestricted
funds
2023
Direct MBII costs
168,998
168,998
144.575
Page 20

Docusiw Envelope ID,, 8F493428-4E8F4EOC-9803-BC907044CFF5
DEMENTIA RESEARCH UK
A Company L¥mited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
ExpÈndlture on r8lslng funds {continu•dl
Fundralslng trading expenses
Total
Total
funds
funds Charlty only
2023
2022
Unrestricted
funds
2023
Wages and salaries
Soclal securlly costs
Pension costs
37.243
4,068
3,400
37,243
4,068
3,400
44,711
44,711
Analysis of grant$
Total
Total
funds
funds Charlly only
2023
2022
Grants to
Institutions
2023
Charitable actniilies
385,000
385,ClOO
282,500
Analysis of 8xp8nditura by actlvltles
Activities
undertaken
dlrectly
2023
Grant
lundlng of
activltles
2023
Total
Total
fund$
funds Charlty tsnly
2023
2022
Support
costs
2023
Governance oosls
21,647
51,108
21,647
653,944
31,303
354,021
Charitable activities
217,836
385.000
217,836
385,000
72,755
675,591
386,324
Page 21

Docuslgn Enveknpe ID.. 8F4934284E8F4EOC-9B03-BC907044CFF5
DEMENTIA RESEARCH UK
IA Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
Analysis of expenditure by activities Icontinuedl
Analysis of direct costs
Total
Total
funds
funds Charlty only
2023
2022
staff costs
Eéucallon
Sundries
44,711
168,999
4,126
16,064
3.294
217,836
19,358
Analysls of 5UPPOrt costs
Totsl
Total
funds
funds Charity only
2023
2022
GovErnance
costs
2023
Charitable
activities
2023
Other
Finance
47.990
3,118
47,990
3,118
21,647
49,905
2,258
31,303
Govarnanca costs
21,647
21,647
51.108
72,755
83,466
Ngt Incomel{frxpondlture)
Nel incomellexpenditurel ol the Group is ststed after charging..
Charity only
2022
2023
Audllorfs remuneration
12.500
7,500
Page 22

Docu￿￿ Env81ope ID.. 8F493428.4E8F4EO&OBO$BC907044CFFS
DEMENTIA RESEARCH UK
IA Company Llmlted by Guarantee}
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
Audltorfs remuneration
Charlty only
2022
2023
Fees payable to the CoMpan￿S auditor for th8 aijdil of the Companls
annual accounts
12,500
7.500
staff costs
Group
Group Charlty only
2023
2022
Wages And salaries
Social securily costs
Pènsion ¢osls
74,486
8,136
6,800
89,422
The averag8 number of parsons amployèd by th8 Company during the year was as follows..
Group
Group Charity only
2023
2022
No.
No.
Staff tngmb8rs
No employee received remuneratiDn amounting lo more than £60,000 in 8ilhar y8ar.
Tha total employè& benoflls of thè key management personnel of the Group were £47,313 {1 person)
{2022.. £nil10 peoplell-
10. Trustses. remunoration and expenses
There were no Iruslees, remuneration or other benefits for the year ended 31 Octrjber 2023 nor for the
year ended 31 October 2022.
There were nD Twstees, expenses pald for the year ended 31 October 2023 nor for the year ended 31
October 2022.
Page 23

not￿SIgn Envelope ID.. 8F493428-4E8F4EOC-9803-BC907044CFF5
DEMENTIA RESEARCH UK
IA Company Llmlt8d by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
11. Flxed asset Investmgnts
Investments
5ub$ldlary
companies
Company
Cost or v8lu8tlon
Additions
100,002
Al 31 October 2023
100.002
Net book value
At 31 October 2023
100,002
Prlnclpal subsldlarlos
The following was a subsidiary undertaking of the Company..
Namo
Company
number
Class of
shares
Holdlng
Included In
consolldatlon
Dornanlia Research Tradlng Limlled
14455544
Ordinary
100Yo Yes
The financial results of the subsidiary for the year wgre-
Name
Expenditure
PTofitllLo$s)
I SuTplusl
IDofl¢lt) for
the year
Nèt a$sot$
D8m8nlia R8s8arch Trading Limited
189,9541
89.954
10.048
12.
Debtor8
Group
Group Charlty only
2023
2022
Company
Company Charity only
2023
2022
Due wlthln one year
Other debtors
42,970
35,806
42.835
35,806
42,970
35,806
42,835
35,806
Page 24

Do￿u￿9￿ Envebpe ID.. 8F4934284E8F4EOC-9B03-BC907044CFF5
DEMENTIA RESEARCH UK
{A Company Llmlted by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
13. Credltors: Amounts falling due within one year
Group
Group
Charlty only
2022
Company
Company
Charity only
2022
2023
2023
Trade credltors
other creditors
108,648
12,461
55,201
108.648
55,2C>1
121,109
55,201
108,650
55,201
14.
Flnanclal Instrument5
Group
Group Charlty Only
2023
2022
Company
2023
Company
2022
Flnanelal assets
Flnanclal ass81s m888ured al fair valu8
through incom@ and oxpgndilure
542,302
324.602
519.930
324,602
Financial ass8ts measured al falr value thfough Inccjme and expenditure comprise cash at bank and In
hand.
Page 25

DotytssEgn Envebpe ID.. 8F493428-4E8F4E￿-9BO8-8C907O44CFf5
DEMENTIA RESEARCH UK
IA Company Llmited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
15. Statement of funds
Statement of funds - curront yèar
Charlty only
Balance at 1
November
2022
B8lan¢e at
31 October
2023
Income Expendilure
Unrestrlcted funds
Charity fijnds
Subsldlary ￿serveS
305.207
1.048.255
(799.346}
{89.954)
554,117
{89,954}
305.207
1.048,256
{889,300)
464,163
Slatoment of funds- prlor yeaT
Charlty only
Balance at
1 November
2021
Charlty only
Balance at
31 October
2022
Income Expenditure
Unrestricted fund$
Charityfunds
Subsidiary r8s8rv8s
237,405
597,701
(s29,8￿)
305,207
237,405
597,701
1529.899)
305.207
16. Analys1$ of nfyt assets be￿een funds
Analysis of net a8sèts betwe&n funds - current y8ar
Unrestrieted
funds
2023
Total
funds
2023
Current assels
585,272
585,272
1121,1091 1121,1091
cr￿lI￿rS due within one year
Total
464.163
464.163
Page 26

Dw51gn Envelope ID.. 8F49342B.4E8F4EOC-9B03.BC907044CFFS
DEMENTIA RESEARCH UK
IA Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
16. Analysis of net assets betwèen funds lcontlnuedl
Analysls of ngt a$sgts between funds - prlor year
Unreslrictsd Unrestricted
fund5
funds
Charlty only Charlly only
2022
2022
Currènt assets
Credltors due wilhln one yèar
360,408
155,201)
360,408
155,2011
Total
305.207
305.207
17. Re¢on¢lllatlon of net movÉmÈnt In funds to net cash flow from opèratlng actlvltifrs
Group
Group
Charity only
2022
2023
Net income for the year las per Statement of Financial Activities)
158.956
67.802
AdJu$tment$ for:
Increase In debtors
17,1621
65,906
19,6861
26,693
Increase in creditors
Net cash provlded by operatlng adlvltles
217,700
84.809
18. Analysis of cash and cash gquivalonts
Group
2023
Group
2022
Cash in hand
542.302
324,602
Total cash and cash equlvalents
542,302
324.602
Page 27

Oocu5tgD EfjvelopB ID.. 8F49342&4E8F4EOC_9B03_Bcg07044CFF5
DEMENTIA RESEARCH UK
{A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
19. Analysls of changes in net debt
At1
November
2022 Cash flows
At31
October
2023
Cash al bank and in hand
324,602
217,700
542,302
324,602
217,700
542,302
20.
P•nslon eommltm8nts
The Group operates a defined eontributlon penslon schèmè. Th6 8ssels of the scheme are held
separately from those of the Group in an indepgndently admlnlslered fund. The penslon cost charge
represents contributions payabla by the Group to the fund. £5SD12022 - £nlll was payable to the fund at
the ba18nce she8t date and aro includod in ¢redilois.
21. Related party transa¢tlons
There ar8 no donations Irorn related partl85 whlch are oulslde the normal ¢ourse of business and no
restricted donations from relalad partles.
No Trustee or othor person related lo the Charity had any personal interest in any contract of Iransacllon
entered into by the Charity, including guarantees, during the ye8r12022 - £nill.
22. Post balance 8h8et ovents
There have been no signrficanl events affecllng thè Group slnco the year end.
23. Controlllng party
Tha Trusl&es make up the membership of the ch8ri18ble company. There Is no overall controlling party.
Pag8 28